Verrica Pharmaceuticals Faces Delisting Notice
Ticker: VRCA · Form: 8-K · Filed: Jul 30, 2025 · CIK: 1660334
| Field | Detail |
|---|---|
| Company | Verrica Pharmaceuticals Inc. (VRCA) |
| Form Type | 8-K |
| Filed Date | Jul 30, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Verrica Pharmaceuticals got a notice about potentially being delisted. Big trouble.
AI Summary
Verrica Pharmaceuticals Inc. filed an 8-K on July 30, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard as of July 24, 2025. The company is incorporated in Delaware and its principal executive offices are located in West Chester, PA.
Why It Matters
This filing indicates potential issues with Verrica Pharmaceuticals' compliance with stock exchange listing requirements, which could lead to its shares being delisted.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and investor confidence.
Key Players & Entities
- Verrica Pharmaceuticals Inc. (company) — Registrant
- July 24, 2025 (date) — Date of earliest event reported
- July 30, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- West Chester, PA (location) — Principal Executive Offices
- 484-453-3300 (phone_number) — Registrant's telephone number
FAQ
What is the specific reason for Verrica Pharmaceuticals Inc. receiving a notice of delisting or failure to satisfy a continued listing rule?
The filing states it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' but does not specify the exact rule or standard not met in the provided text.
When was the earliest event reported that led to this notice?
The earliest event reported was on July 24, 2025.
What is Verrica Pharmaceuticals Inc.'s state of incorporation?
Verrica Pharmaceuticals Inc. is incorporated in Delaware.
Where are Verrica Pharmaceuticals Inc.'s principal executive offices located?
The principal executive offices are located at 44 West Gay Street, Suite 400, West Chester, PA 19380.
What is the filing date of this 8-K report?
This 8-K report was filed on July 30, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 30, 2025 regarding Verrica Pharmaceuticals Inc. (VRCA).